Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroacupuncture for Chemotherapy-Induced Gastrointestinal Symptoms in Breast Cancer
NCT06952920Phase 3Recruiting
- Start
- Aug 2025
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms). Primary endpoint: Incidence of chemotherapy-induced gastrointestinal symptom clusters at 120 hours. Started Aug 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06952920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06952920.